Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Finasteride use may increase the risk of male breast cancer.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Low zinc levels may be linked to the return of gynecologic cancers.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Elaine Fuchs' research shows how skin stem cells maintain health, aid in healing, and are involved in cancer.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Non-invasive methods can effectively monitor skin inflammation and cancer biomarkers.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Frequent use of chemical hair relaxers may increase endometrial cancer risk in Black women.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Minoxidil may help with hair loss caused by cancer treatments.

PCOS may increase the risk of certain cancers.